The Centre has sanctioned funds from the PMCares Fund for setting up a vaccine-testing laboratory here, Union Minister of State for Home G Kishan Reddy said on Saturday.
I thank Honble PM Shri narendramodi Ji for sanctioning funds for setting up of Vaccine Testing Lab at Hyderabad. A big step forward towards comprehensive development of pharma sector in Hyderabad, which will also boost production of COVID-9 vaccines, Reddy, a Lok Sabha member from Secunderabad, tweeted.
The increased focus on vaccine production against the backdrop of COVID-19 pandemic has necessitated more vaccine- testing laboratories in the country, Reddy said in a press release.
At present, there are two vaccine-testing laboratories in the country -- the Central Drug Laboratory at Kasauli and National Institute of Biologicals at Noida, he said.
Funds have been released from the PMCARES Fund on March 6 for establishing two more such laboratories -- one at National Centre for Cell Science, Pune, and the other at the National Institute of Animal Biotechnology, Hyderabad, under the Department of Biotechnology, he said.
The laboratory in Hyderabad is expected to commence operations in the next one month, he said.
The setting up of the new laboratory is a big step towards the comprehensive development of the pharma sector in Hyderabad as the city is home to many pharma majors, COVID-19 vaccine production companies and other R & D institutions, he said.
It would also boost the production of COVID-19 vaccines, Reddy said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU